About Us
PARTNERS
A2 Bio Partners

A2 Bio has a collaboration with Merck for its first allogeneic program and an option for a second program. This is Merck’s first partnership in the cell therapy area, and their decision to partner with A2 Bio serves as a validation of the Tmod™ platform. Learn More

A2 Bio has a collaboration with Tempus, a leader in genetic diagnostic testing, artificial intelligence and precision medicine, to develop a companion diagnostic to identify patients whose tumors have lost HLA-A*02. Learn More
To explore potential partnership opportunities, please contact us at [email protected]